ABBV-3373
Product Specifications
Target
Glucocorticoid Receptor|||Antibody-Drug Conjugates (ADCs) |||TNF
Related Pathways
Apoptosis|||Endocrinology/Hormones|||Antibody-drug Conjugate/ADC Related
Bioactivity
ABBV-3373 is an anti-TNF antibody-drug conjugate (ADC) composed of the humanized TNF antibody adalimumab and a glucocorticoid receptor agonist. It is designed for use in research related to rheumatoid arthritis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
I8443-78A-FITC 200 µL
IL29, ID (Interleukin-29, IL-29, Interferon lambda-1, IFN-lambda-1, Cytokine ZCYTO21, FNL1, ZCYTO21, IL29) (FITC) discontinued
Ask
View Details 
